louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT01177748: Stroke Arrhythmia Monitoring Database
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Acute Stroke
Keywords: Stroke
Cardiac Monitoring
Lead sponsor: University of Erlangen-Nürnberg Medical School
Sponsor class: OTHER
First posted: 2010-08-09
Enrollment: 501
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients suffering from acute cerebral injury treated on a specialized Stroke Unit

Brief summary: Cardiac arrhythmia are frequently observed after stroke. They may on one hand be causative for the stroke mainly in case of atrial fibrillation but on the other hand present severe complications of the stroke. In addition, cardiac comorbidity as well as acute myocardial infarction are frequently found in acute stroke patients. Diagnostics to identify cardiac arrhythmia in the acute phase of stroke care thus have an important role not only for adjusting the correct secondary prevention but also to prevent cardiac complications potentially reducing morbidity and mortality.

The aim of the SAMBA-Study is to systematically assess the prevalence of higher grade arrhythmias after stroke using a standardized reading of 72h telemetric monitoring in the first days after stroke onset. In addition, it evaluates different strategies to identify paroxysmal atrial fibrillation.


Eligibility criteria: Inclusion Criteria:

* Patients treated on the stroke unit
* Patients with telemetric monitoring

Exclusion Criteria:

* None

Primary outcomes:
measure: Prevalence of high grade cardiac arrhythmia after stroke
timeFrame: 72 hours
Secondary outcomes:
measure: Detection of paroxysmal atrial fibrillation by different diagnostic approaches
timeFrame: 72 hours
measure: Cerebral lesion distribution in patients with cardiac arrhythmia
timeFrame: 72 hours
measure: Impact of arrhythmia on clinical outcome and mortality after 90 days
timeFrame: 90 days post stroke
Other outcomes:
Locations:
city: Erlangen
country: Germany
facility: University Hospital Erlangen, Dept. of Neurology
state: Bavaria
Study officials:
affiliation: Universityhospital Erlangen; Dept. of Neurology
name: Martin Köhrmann, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Kallmunzer B, Breuer L, Hering C, Raaz-Schrauder D, Kollmar R, Huttner HB, Schwab S, Kohrmann M. A structured reading algorithm improves telemetric detection of atrial fibrillation after acute ischemic stroke. Stroke. 2012 Apr;43(4):994-9. doi: 10.1161/STROKEAHA.111.642199. Epub 2012 Feb 2.
citation: Kallmunzer B, Breuer L, Kahl N, Bobinger T, Raaz-Schrauder D, Huttner HB, Schwab S, Kohrmann M. Serious cardiac arrhythmias after stroke: incidence, time course, and predictors--a systematic, prospective analysis. Stroke. 2012 Nov;43(11):2892-7. doi: 10.1161/STROKEAHA.112.664318. Epub 2012 Sep 6.
Clinical trial NCT00289848: MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)
Official title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of MK0431 in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE3
Conditions: Type 2 Diabetes Mellitus
Lead sponsor: Merck Sharp & Dohme LLC
Sponsor class: INDUSTRY
First posted: 2006-02-10
Enrollment: 530
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.


Eligibility criteria: Inclusion Criteria:

* Patients have Type 2 Diabetes Mellitus and have laboratory results that are within the values established by the study such as an Hemoglobin A1c (HbA1c) \>=7.5% and \<=11% and a Fasting Plasma Glucose (FPG) \>=130 mg/dL and \<=280 mg/dL

Exclusion Criteria :

* Patients have Type 1 Diabetes Mellitus or required insulin therapy within the past 12 months

Primary outcomes:
measure: Change From Baseline in Hemoglobin A1c (HbA1c) at Week 18
timeFrame: Baseline and Week 18
Secondary outcomes:
measure: Change From Baseline in Fasting Plasma Glucose (FPG) at Week 18
timeFrame: Baseline and Week 18
measure: Change From Baseline in 2-hr Post-Meal Glucose (PMG) at Week 18
timeFrame: Baseline and Week 18
Other outcomes:
Locations:
Study officials:
affiliation: Merck Sharp & Dohme LLC
name: Medical Monitor
role: STUDY_DIRECTOR
References:
citation: Mohan V, Yang W, Son HY, Xu L, Noble L, Langdon RB, Amatruda JM, Stein PP, Kaufman KD. Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea. Diabetes Res Clin Pract. 2009 Jan;83(1):106-16. doi: 10.1016/j.diabres.2008.10.009. Epub 2008 Dec 20.
citation: Singh B, Sims H, Trueheart I, Simpson K, Wang KC, Patzkowsky K, Wegman T, Soma JM, Dixon R, Jayes F, Voegltine K, Yenokyan G, Su SC, Leppert P, Segars JH. A Phase I Clinical Trial to Assess Safety and Tolerability of Injectable Collagenase in Women with Symptomatic Uterine Fibroids. Reprod Sci. 2021 Sep;28(9):2699-2709. doi: 10.1007/s43032-021-00573-8. Epub 2021 Apr 29.
Clinical trial NCT00713973: Comparative Study Between Thrombosis Prophylaxis Protocols
Official title: Comparative Study Between American and Brazilian Protocols for Deep Venous Thrombosis Prophylaxis: a New Proposal
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Prophylaxis of Deep Vein Thrombosis
Lead sponsor: UPECLIN HC FM Botucatu Unesp
Sponsor class: OTHER
First posted: 2008-07-14
Enrollment: 212
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients who underwent plastic surgery in the Hospital of the Medical School of Botucatu, in the period of one year.

Brief summary: Background: Compare the American and Brazilian protocols for prophylaxis of deep vein thrombosis (DVT), seeking to draft a new protocol, more comprehensive and applicable. Methods: A prospective study was conducted over a year, covering 212 patients, comparing the protocols on the stratification of risk of DVT, and the type of prophylaxis indicated. A new protocol was proposed, applied and compared to previous.

Detailed description: Not desired

Eligibility criteria: Inclusion Criteria:

Patients who underwent plastic surgery in the Hospital of the Medical School of Botucatu, in the period of one year

Exclusion Criteria:

refusal to participate in the research protocol

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
city: Botucatu
country: Brazil
facility: University Hospital of UNESP
state: São Paulo
Study officials:
affiliation: UPECLIN HC FM Botucatu Unesp
name: JORGE L MOULIM
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT02719873: The Impact of Maternal Obesity on Pregnancy Outcomes in El-Minia Locality
Official title: The Impact of Maternal Obesity on Pregnancy Outcomes in El-Minia Locality a Case Control Survey Study
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Obesity During Pregnancy in Clinical Practice
Keywords: obesity , pregnancy , maternal and fetal outcome
Lead sponsor: Minia University
Sponsor class: OTHER
First posted: 2016-03-25
Enrollment: 330
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: pregnant women with BMI more than 24 per meter square body surface area

Brief summary: A study will carried out over a period of one year , all obese pregnant women as diagnosed with BMI at the time of 1st ANC visit and before labor ,observation of events during both intra-partum \&postpartum periods it will be recorded.outcome will compared with normal other pregnant women

Detailed description: It is known that obesity during pregnancy has drawbacks for both maternal and foetal outcome The aim of this study is to evaluate and measure the proportion of the adverse pregnancy outcomes attributable to maternal obesity and so reaching to recommendations in order to improve the outcomes and wellbeing of these women and their children.patient will be divided into two groups control group with normal BMI and study group and both compared as regard foetal and maternal outcome The assessed fetal variables will be: fetal birthweight \& incubators admission. Data will be retrieved from patients before labor and from investigator observation both intrapartum and postpartum.

Eligibility criteria: Inclusion Criteria:

* obese
* pregnant
* age 18 -40
* single viable cephalic foetus

Exclusion Criteria:

less than 18 years more than 40 years associated medical disorders patient refusal non cephalic presentation

-

Primary outcomes:
measure: Mode of delivery
timeFrame: onset of labor till end
measure: shoulder dystocia
timeFrame: 1 minute after delivery of the head
measure: foetal macrosomia
timeFrame: at time of labour or elective CS
Secondary outcomes:
measure: postpartum hemorrhage
timeFrame: onset of labor and for 6 weeks after
measure: postpatum maternal infection
timeFrame: end of labor and for 6weeks after
measure: neonatal ICU admission
timeFrame: one month after delivery
Other outcomes:
Locations:
city: Minia
country: Egypt
facility: Minia University
Study officials:
References:
citation: Stuber TN, Kunzel EC, Zollner U, Rehn M, Wockel A, Honig A. Prevalence and Associated Risk Factors for Obesity During Pregnancy Over Time. Geburtshilfe Frauenheilkd. 2015 Sep;75(9):923-928. doi: 10.1055/s-0035-1557868.
Clinical trial NCT00505973: Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects
Official title: An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SCA-136 Administered Orally to Healthy Japanese Male Subjects
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE1
Conditions: Schizophrenia
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Sponsor class: INDUSTRY
First posted: 2007-07-25
Enrollment: 24
Sex: MALE
Minimum age (years): 20
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: This study is being conducted to assess the safety and tolerability of ascending multiple oral doses of SCA-136 administered to healthy Japanese male subjects.


Eligibility criteria: Inclusion criteria:

* Healty Japanese men willing to use a medically acceptable form of contraception.

Exclusion criteria:

* Any significant disease
* Positive urine drug screen
* Increased liver function tests
* Use of prescription drugs.

Primary outcomes:
measure: Adverse events, safety laboratory results, vital signs, and ECGs will be used to monitor subject safety.
Secondary outcomes:
Other outcomes:
Locations:
city: Ikebukuro
country: Japan
state: Toshima-ku
Study officials:
affiliation: Wyeth is now a wholly owned subsidiary of Pfizer
name: Medical Monitor
role: STUDY_DIRECTOR
References:
Clinical trial NCT01712373: Ginseng in Treatment of Fatigue in Multiple Sclerosis
Official title: Study of Ginseng in Treatment of Fatigue in Multiple Sclerosis
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE2
Conditions: Fatigue
Keywords: Multiple sclerosis
Ginseng
Fatigue
Quality of life
Lead sponsor: Isfahan University of Medical Sciences
Sponsor class: OTHER
First posted: 2012-10-23
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study was to evaluate the efficacy and safety of Ginseng in treatment of fatigue and Quality of Life of MS patients.

Detailed description: Multiple Sclerosis (MS) is one of the most common non-traumatic causes of disability in the world. It is a chronic inflammatory and demyelinating disorder of the Central Nervous System (CNS) which affects individuals in the productive ages and causes a large burden for years to come. Fatigue is a common complaint and one of the least understood symptoms of MS

Eligibility criteria: Inclusion Criteria:

* definite diagnosis of relapsing-remitting MS (RRMS) by the MacDonald criteria with a baseline of Expanded Disability Status Score (EDSS)of less than 5.0

Exclusion Criteria:

* prior use of ginseng or any other tonic agents, glucocorticoids, warfarin, digoxin, aspirin, furosemide, caffeine, ephedra and anti-platelet agents within one month prior to enrollment;
* Pregnancy or lactation;
* history of renal failure; and,
* lack of appropriate adherence to the study protocol.

Primary outcomes:
measure: Fatigue
timeFrame: at 3 months after treatment
Secondary outcomes:
measure: Quality Of Life
timeFrame: at 3 months after treatment
Other outcomes:
Locations:
city: Isfahan
country: Iran, Islamic Republic of
facility: Al-zahra university hospital
Study officials:
affiliation: MD, Research Assistant
name: mahboobe esfahani, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT04113473: An Evaluation of Yoga Therapy for Cervical Spondylosis
Official title: Effectiveness of Yoga Therapy for Neck Pain Relief in Patients With Cervical Spondylosis
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cervical Spondylosis
Neck Pain
Lead sponsor: NMP Medical Research Institute
Sponsor class: OTHER
Collaborators: name: Yog-Kulam
First posted: 2019-10-02
Enrollment: 62
Sex: ALL
Minimum age (years): 18
Maximum age (years): 55
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: Cervical spondylosis is a chronic degenerative condition, commonly affecting \>40-year-old adults worldwide. Cervical spondylosis is an important cause of neck pain and low back pain, and seriously affects the physical health, mental health, patients quality of life. Yoga has been most commonly used intervention for pain conditions. But its efficacy in cervical spondylosis has not yet been studied in clinical trials. The primary aim of the present study was to assess the efficacy of yoga chikitsa (therapy) compared with control intervention for neck pain caused by cervical spondylosis.


Eligibility criteria: Inclusion Criteria:

* Neck pain of CS as per diagnostic criteria of International Classification of Diseases
* CS supported by a physical examination, and cervical radiographic examination
* History of neck pain longer than 3 months
* willing to provide informed consent

Exclusion Criteria:

* History of neck trauma, fracture or surgery,
* Systematic disease of the neck or spine including bones and joints conditions,
* Pregnancy

Primary outcomes:
measure: Neck pain
timeFrame: Change from baseline to 12 weeks
Secondary outcomes:
measure: Disability
timeFrame: Change from baseline to 12 weeks
measure: Health related Quality of Life
timeFrame: change from baseline to 12 weeks
Other outcomes:
Locations:
city: Jaipur
country: India
facility: Pain Clinic, NMP Medical Research Institute
state: Rajasthan
Study officials:
affiliation: Yog-Kulam
name: Neha Sharma, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: NMP Medical Research Institute, India
name: Shekhar Sharma
role: STUDY_DIRECTOR
affiliation: Yog-Kulam
name: Jaydeep Joshi
role: STUDY_CHAIR
References:
Clinical trial NCT03430531: Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Official title: Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache; A Pilot Study
Study type: INTERVENTIONAL
Overall status: TERMINATED
Phase: PHASE2
Conditions: Post-Dural Puncture Headache
Sphenopalatine Ganglion Block
Lead sponsor: Milton S. Hershey Medical Center
Sponsor class: OTHER
First posted: 2018-02-13
Enrollment: 6
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: Open-label, single arm, pilot study
Primary purpose: TREATMENT

Brief summary: The objective of the study is to determine the effectiveness of Spheno-Palatine (SP) ganglion block to alleviate the pain of post-dural puncture headache (PDPH).

Detailed description: The primary objectives of the study are to study the effectiveness of SP ganglion block in relieving post-dural puncture headache in terms of :

1. Number of subjects who get relief of pain
2. The onset time to pain relief after application of block
3. The duration of pain relief
4. The incidence of recurrence of post-dural puncture headache

Secondary objectives are to:

1. Monitor any complications due to SP ganglion block
2. Measure patient satisfaction
3. Monitor any residual effects at 1 months after the SP block

Eligibility criteria: Inclusion Criteria:

1. Complains of symptoms suggestive of post-dural puncture headache
2. Has a history of dural puncture (lumbar puncture or accidental dural puncture during epidural placement) within the previous 7 days
3. Fluent in written and spoken English

Exclusion Criteria:

1. Those with a known history of hypersensitivity to local anesthetics of the amide type or to other components of GLYDO
2. Those with any congenital or acquired, anatomical deformity of the nostril, which preclude performing the block
3. Those who refuse to consent to participate in the study
4. Patients who have had a failed epidural blood patch
5. Cognitive Impairment
6. Prisoner

Primary outcomes:
measure: Pain Score at Baseline
timeFrame: 15 minutes before the SP block
measure: Pain Score 60 Minutes Post-SP Block
timeFrame: 60 minutes
measure: Pain Score 1 Day Post-SP Block
timeFrame: 1 day
measure: Pain Score 2 Days Post-SP Block
timeFrame: 2 days
measure: Pain Score 7 Days Post-SP Block
timeFrame: 7 days
measure: Pain Score 30 Day Post-SP Block
timeFrame: 30 days
Secondary outcomes:
measure: Duration of Pain Relief
timeFrame: 24 hours
measure: Number of Participants With Recurrence of Post-dural Puncture Headache
timeFrame: 7 days
measure: Number of Participants With Complications Due to SP Ganglion Block
timeFrame: 15 minutes before the SP block to 30 days post SP block
Other outcomes:
Locations:
city: Hershey
country: United States
facility: Milton S. Hershey Medical Center
state: Pennsylvania
Study officials:
affiliation: Milton S. Hershey Medical Center
name: Verghese Cherian, MD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT03021031: Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core
Official title: Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core
Study type: OBSERVATIONAL
Overall status: ENROLLING_BY_INVITATION
Conditions: Parkinson Disease
Keywords: Parkinson's Disease
Lead sponsor: University of Minnesota
Sponsor class: OTHER
First posted: 2017-01-13
Enrollment: 60
Sex: ALL
Minimum age (years): 21
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: People with Parkinson's Disease

Brief summary: The goal of this project is to provide comprehensive longitudinal assessments of a cohort of PD patients before, during, and after DBS surgery, including neurological, neurophysiological, and neuropsychological data.


Eligibility criteria: Inclusion Criteria:

* Age 21 years and older
* Diagnosis of Parkinson's disease
* Candidate for DBS

Exclusion Criteria:

* Diagnosis of dementia
* Pregnant women

Primary outcomes:
measure: Registry
timeFrame: 5 Years
Secondary outcomes:
Other outcomes:
Locations:
city: Minneapolis
country: United States
facility: University of Minnesota
state: Minnesota
Study officials:
References:
Clinical trial NCT06261931: Severity Over Time of Early Forms of Spondyloarthritis
Official title: Severity Over Time of Early Forms of Spondyloarthritis, a Prospective Observational Study.
Study type: OBSERVATIONAL
Overall status: NOT_YET_RECRUITING
Conditions: Spondyloarthritis
Spondyloarthritis, Axial
Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sponsor class: OTHER
First posted: 2024-02-15
Enrollment: 387
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: patients with recent onset of SpA (duration of symptoms ≤2 years) and diagnosis made by the rheumatologist.

Brief summary: Spondyloarthritis (SpA) is a group of chronic inflammatory pathologies whose progression over time is poorly defined, and in particular the clinical and instrumental elements that can predispose to a condition of disease severity are not completely known. It would be important to have an idea of what the predisposing factors are, possibly already at baseline, and possibly also at follow up, of severe disease, so as to be able to act early with more aggressive and targeted therapies on these patients, so as to achieve remission.


Eligibility criteria: Inclusion Criteria:

* age \&gt;18 years;
* Diagnosis of SpA confirmed by the rheumatologist with duration of symptoms \&lt;
* 2 years;
* Signature of the written informed consent to the study

Exclusion Criteria:

* Age \&lt; 18 years;
* Patients suffering from other rheumatic pathologies (even in overlap), or genetic diseases such as Marfan syndrome, Ehlers Danlos syndrome
* Any medical or psychiatric condition that in the judgment of the investigator would prevent the participant from complying with the protocol or completing the study according to the protocol.
* Refusal to sign the informed consent to the study.

Primary outcomes:
measure: spondyloarthritis severity
timeFrame: t0 baseline 3hours, t1 3 months 3hours,t2 6 months 3hours,t2 12months 3hours,every six months up to the tenth year
Secondary outcomes:
Other outcomes:
Locations:
city: Roma
country: Italy
facility: Fondazione Policlinico Universitario A. Gemelli IRCCS
Study officials:
References:
Clinical trial NCT00000231: Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
Official title: Buprenorphine Detoxification With Two Types of Treatment. BBD IV
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE2
Conditions: Opioid-Related Disorders
Lead sponsor: National Institute on Drug Abuse (NIDA)
Sponsor class: NIH
Collaborators: name: University of Vermont
First posted: 1999-09-21
Enrollment: 0
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with pro-social activities. In addition, we will examine whether blind naltrexone dosing is effective in indicating naltrexone consumption.


Eligibility criteria: Please contact site for information.

Primary outcomes:
measure: Drug use
measure: Retention
measure: Weeks abstinent
measure: Weeks continuous abstinence
measure: Overall treatment outcome
measure: Naltrexone consumption
Secondary outcomes:
Other outcomes:
Locations:
city: Burlington
country: United States
facility: Treatment Research Center
state: Vermont
Study officials:
affiliation: University of Vermont
name: Warren Bickel, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References:
citation: Bunyoz KI, Tsikandylakis G, Mortensen K, Gromov K, Mohaddes M, Malchau H, Troelsen A. No difference in whole-blood metal ions between 32-mm and 36- to 44-mm femoral heads in metal-on-polyethylene total hip arthroplasty: a 2-year report from a randomised control trial. Hip Int. 2023 Mar;33(2):184-192. doi: 10.1177/11207000211022623. Epub 2021 Jun 8.